Replies to post #248 on Biotech Values

[DewDiligence]

>> When he offers his view of what’s going on and what is important, I get the feeling it’s worth considering. <<

I agree, and I do take ridge_runner’s comments very seriously.

But no one should be entitled to a free pass. When ridge_runner is wrong (as he is on the discussion of the endpoint in the Lomucin trial), I will take the opportunity to point it out. Regards, Dew